Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

Abstract Background: There are currently no methods to predict the development of levodopa-induced dyskinesia (LID), a frequent complication of Parkinson's disease (PD) treatment. Clinical predictors and single nucleotide polymorphisms (SNP) have been associated to LID in PD. Objective: To...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bruno Lopes SANTOS-LOBATO, Artur F. SCHUMACHER-SCHUH, Carlos R. M. RIEDER, Mara H. HUTZ, Vanderci BORGES, Henrique Ballalai FERRAZ, Ignacio F. MATA, Cyrus P. ZABETIAN, Vitor TUMAS
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2020-04-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	dyskinesia Parkinson disease levodopa decision support techniques
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000400206&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Inefficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease Patients with Levodopa-Induced Dyskinesias: Results from a Pilot Study
by: Alma Medrano-Hernández, et al.
Published: (2025-07-01)

Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster
by: Herbert Izo, Ninsiima, et al.
Published: (2020)

USE OF THREE-COMPONENT LEVODOPA (LEVODOPA/CARBIDOPA/ENTACAPONE) TO CORRECT NOCTURNAL SYMPTOMS OF PARKINSON,S DISEASE
by: T. K. Kulua, et al.
Published: (2015-08-01)

Symptom improvement in a South Asian patient with Parkinson’s disease treated with immediate- and extended-release carbidopa–levodopa: a case report
by: Gail Reiner, et al.
Published: (2025-07-01)

How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson’s disease
by: Robert A. Hauser, et al.
Published: (2025-01-01)

Possibilities of group chronophysiotherapy at gall-bladder dyskinesias
by: O. A. Poddubnaya, et al.
Published: (2012-02-01)

Continuous Dopaminergic Stimulation-Based Levodopa Treatment in Patients with Early to Mid-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Rong Tang, et al.
Published: (2025-05-01)

Primary Ciliary Dyskinesia Registry
by: Mohammadreza Modaresi, et al.
Published: (2024-01-01)

Modern Approaches to the Diagnosis and Management of Children With Primary Ciliary Dyskinesia
by: A. A. Baranov, et al.
Published: (2017-05-01)

Effect of levodopa and clioquinol on antioxidant capacity in Parkinson’s disease rhesus monkeys
by: LI Like, et al.
Published: (2017-05-01)

Dementia with Lewy bodies
by: O. S. Levin, et al.
Published: (2018-11-01)

Tratamento da doença de Parkinson
by: Francisco Cardoso
Published: (1995-03-01)

Dyskinesia induced by phenytoin Discinesia induzida por fenitoína
by: M. AUGUSTA MONTENEGRO, et al.
Published: (1999-06-01)

Paroxysmal Dyskinesias Secondary to HHV‐6A Encephalitis: The First Case Report and Literature Review
by: Zhuoran Wang, et al.
Published: (2025-08-01)

Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier
by: Kaili Liang, et al.
Published: (2024-12-01)

Sertraline treatment for paroxysmal nonkinesigenic dyskinesia comorbid with anxiety and depression
by: Munetsugu Hara, et al.
Published: (2024-09-01)

STUDY OF RAPITALAM INFLUENCE ON OXOTREMORINE-INDUCED TREMOR
by: N. V. Avdeeva
Published: (2019-05-01)

Is chronic neck pain related to scapular dyskinesia? A systematic review
by: Norollah Javdaneh, et al.
Published: (2025-07-01)

Gluten and its relationship with inflammation and Parkinson's Disease: A literature review
by: Zohaer Muttalib, et al.
Published: (2025-03-01)

Quantitative analysis of gait parameters in Parkinson’s disease and the clinical significance
by: Wenchao Yin, et al.
Published: (2025-08-01)

Identifying the diagnostic gap of tardive dyskinesia: an analysis of semi-structured electronic health record data
by: Kira Griffiths, et al.
Published: (2025-04-01)

A quasi-experimental investigation of scapular stabilization exercises on muscle coordination and functional recovery in scapular dyskinesia
by: Sneha M, et al.
Published: (2025-08-01)

Empowering limited-resource countries: collaborating with expert centers for diagnosis of primary ciliary dyskinesia
by: Mine Yuksel Kalyoncu, et al.
Published: (2025-03-01)

Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review
by: Vitor Tumas, et al.
Published: (2025-03-01)

Fluoxetine-Induced Dyskinesia in a Pediatric Patient: A Case Report and Literature Review on Implications of Polypharmacy and Serotonergic Regulation
by: Mehmet Ayhan Cöngöloğlu, et al.
Published: (2025-08-01)

IMPULSIVE-COMPULSIVE DISORDERS IN PARKINSON'S DISEASE. CLINICAL CASES
by: N. V. Fedorova, et al.
Published: (2015-10-01)

Clinical characteristics of multiple system atrophy in Serbian population
by: Nešić Nada, et al.
Published: (2006-01-01)

Impulse control and related disorders in Parkinson’s disease
by: Antonio Pedro Vargas, et al.

The effect of antipsychotic-induced extrapyramidal disorders on patient’s compliance with schizophrenia (a clinical case)
by: E. G. Rahim, et al.
Published: (2022-01-01)

Transient dysarthria and hemiparesis in an adolescent
by: Yasutaka Yanagita, et al.
Published: (2025-06-01)

The Role of Critical Shoulder Angle in Predicting the Outcome of Conservative Management of Shoulder Impingement Syndrome
by: Sardar Jaideep Singh, et al.
Published: (2025-08-01)

Validation of the Brazilian version of the Clinical Gait and Balance Scale and comparison with the Berg Balance Scale
by: Jussara Almeida Oliveira Baggio, et al.
Published: (2013-09-01)

DOPAMINE DYSREGULATION SYNDROME IN PARKINSON’S DISEASE AND APPROACHES TO ITS CORRECTION WITH DRUGS
by: S. M. Omarova, et al.
Published: (2017-07-01)

Guidelines for Parkinson’s disease treatment: consensus from the Movement Disorders Scientific Department of the Brazilian Academy of Neurology - motor symptoms
by: Roberta Arb Saba, et al.
Published: (2022-03-01)

The effectiveness of incorporating chest proprioceptive neuromuscular facilitation with conventional chest physical therapy in Kartagener’s syndrome: a case report
by: Nidhi Yadav, et al.
Published: (2025-01-01)

Efficacy of suspension exercise training in spinal cord injury: a systematic review and meta-analysis
by: Yuntao Li, et al.
Published: (2025-07-01)

The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory A precisão do diagnóstico de depressão na doença de Parkinson: um estudo comparativo entre a UPDRS, a escala geriátrica de depressão e o inventário de depressão de Beck
by: Vitor Tumas, et al.
Published: (2008-06-01)

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)